CHEMBL418

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf gptkb:drug
small molecule
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:contraindication asthma
severe bradycardia
cardiogenic shock
gptkbp:discoveredBy gptkb:ICI_Pharmaceuticals
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion gptkb:kidney
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:haspKa 9.6
gptkbp:hasSMILES CC(C)NCC(CO)Oc1ccc(cc1)CC(=O)N
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL418
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
gptkbp:isApprovedDrug true
gptkbp:KEGGID gptkb:D00222
gptkbp:legalStatus prescription only
gptkbp:listedOn gptkb:PubChem
gptkb:ChEBI
gptkb:DrugBank
gptkb:KEGG
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:metabolism liver
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID 2162
CHEBI:2269
DB00335
2249
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
fatigue
bradycardia
cold extremities
gptkbp:synonym gptkb:4-(2-hydroxy-3-isopropylaminopropoxy)phenylacetamide
gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
gptkbp:bfsParent gptkb:Wortmannin
gptkb:paroxetine
gptkb:camptothecin
gptkb:Adenine
gptkb:Physostigmine
gptkbp:bfsLayer 6